Osimertinib-associated erythema dyschromicum perstans-like eruption: A case series.

Autor:	Oh CS; Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York., Martinez MJ; Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York., Meehan S; Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York., Gutierrez D; Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York., Tattersall IW; Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York.
Jazyk:	angličtina
Zdroj:	JAAD case reports [JAAD Case Rep] 2023 Mar 07; Vol. 35, pp. 28-32. Date of Electronic Publication: 2023 Mar 07 (Print Publication: 2023).
DOI:	10.1016/j.jdcr.2023.01.038
Abstrakt:	Competing Interests: Dr Tattersall has received consulting fees from OnQuality Pharmaceuticals. Drs Gutierrez and Meehan and authors Oh and Martinez have no conflicts to disclose.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu